ACADACADIA Pharmaceuticals Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $22.20 (+0.00% today)

Market Cap: $3.78B

P/E (TTM): 9.60

Forward P/E (FY1): 49.30

EPS Growth: 88.8%

Analyst Upside: 51.7%

Relative Strength (RS%): 1

-21.7% from 52-week high

Back to Scanner

ACAD

NASDAQRS 1Score 30

ACADIA Pharmaceuticals Inc.

HealthcareBiotechnology$3.78B2 setups passing
$22.20
0.0% ($0.00)
-21.7% from 52W High
P/E (TTM)
9.60
Fwd P/E
49.30
PEG
Analyst Upside
+51.7%
EPS Growth
88.8%
Gross Margin
91.7%
ROE
41.9%
D/E
0.04
Div Yield
0.0%
Avg Volume
1.7M

Price Chart

Key Levels

SMA 200
$23.73
SMA 50
$23.22
Price
$22.20
52W High
$28.35
Target
$33.67

Setup Radar

2/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst